BSX

Q: What is the price of Boston Scientific (BSX) today?

The price of Boston Scientific (BSX) today is R$ 578,76, with a variation of 33.87% compared to the last year. The price of Boston Scientific (BSX) started the year trading around R$ 485,90 and today it is at R$ 578,76. Follow the real-time price chart, the historical price of Boston Scientific (BSX), and stock data from Ibovespa and international markets.

Q: When does Boston Scientific (BSX) pay dividends?

Boston Scientific (BSX) did not distribute dividends in the last year.

Q: Boston Scientific (BSX) is it worth it?

Currently, Boston Scientific (BSX) is priced at R$ 578,76, with a P/E of 62,73%, representing a deviation of 68,09% from its historical average P/E. In the last year, the stock showed a variation of 33.87% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 33,87%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Boston Scientific (BSX)?

Investing in shares of Boston Scientific (BSX) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Boston Scientific (BSX) yield today?

The yield of Boston Scientific (BSX) was 0,24% in the last month, 33,87% in the last year and 159,30% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Boston Scientific (BSX) today, the total investment would be based on the current price of R$ 578,76.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 77.478,82In 5 years: R$ 150.072,88In 10 years: 367.826,15It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Boston Scientific Corp.

Price

US$ 106,39

variation (12m)

33,87%

p/l

62,73

p/vp

6,94

DIVIDEND YIELD

0,00%

quote BSX

BVMF

BSX

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of BSX

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

0,24%

3 months

1,80%

1 year

33,87%

2 years

97,79%

5 years

159,30%

10 years

535,54%

real profitability

profitability minus inflation.

1 month

0,24%

3 months

1,29%

1 year

27,20%

2 years

80,29%

5 years

89,47%

10 years

276,77%

Indicators BSX

check out the fundamentals of Boston Scientific shares

P/L

62,73

Sector: -1,52 Industry: -3,80

P/SALES (PSR)

8,50

Sector: 1,99 Industry: 2,90

P/VP

6,94

Sector: 2,16 Industry: 1,76

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

6,03%

Sector: -26,53% Industry: -56,94%

ROE

11,06%

Sector: -31,21% Industry: -45,34%

ROIC

8,72%

Sector: -404,40% Industry: -420,46%

Net Margin

13,54%

Sector: -26,56% Industry: -32,35%

GROSS MARGIN

68,27%

Sector: 44,49% Industry: 44,86%

OPERATING MARGIN

18,32%

Sector: -23,10% Industry: -30,21%

P/EBITDA

33,82

Sector: 0,07 Industry: -2,60

P/EBIT

47,17

Sector: -1,37 Industry: -3,22

P/ASSETS

3,78

Sector: 1,23 Industry: 1,32

VPA

15,31

Sector: 3,66 Industry: 1,68

LPA

1,69

Sector: -0,80 Industry: -1,22

EQUITY / ASSETS

0,55

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

13,28%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0,00%

Sector: - Industry: -

FAIR PRICE OF Boston Scientific ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 106,39

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-77,32%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

BSX indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
LLY	45,25	34,03	75,21%	0,81%	US$ 624,41 B	25,91%
ISRG	65,56	9,52	14,52%	0,00%	US$ 170,94 B	28,51%
TMO	28,71	3,73	13,01%	0,33%	US$ 189,00 B	15,24%
MDT	25,50	0,00	0,00%	3,03%	US$ 118,85 B	13,63%
SNY	11,17	1,55	13,90%	4,31%	US$ 125,86 B	14,83%
CVS	19,92	1,16	5,84%	3,73%	US$ 90,27 B	1,17%
GSK	17,94	4,15	23,12%	4,04%	US$ 80,77 B	10,87%
ABT	15,66	4,31	27,50%	1,81%	US$ 218,97 B	32,43%
NVS	18,12	5,88	32,47%	3,05%	US$ 247,36 B	24,74%
TMDX	56,86	12,81	22,53%	0,00%	US$ 4,07 B	13,49%
HCA	16,35	-78,84	-482,31%	0,68%	US$ 97,60 B	8,21%
INMD	5,22	1,48	28,44%	0,00%	US$ 933,03 M	44,50%
DHR	44,49	2,90	6,52%	0,56%	US$ 151,86 B	14,21%
IDXX	52,40	35,40	67,57%	0,00%	US$ 51,64 B	24,41%
FMS	20,59	0,91	4,42%	3,07%	US$ 15,03 B	3,41%
HUM	23,00	1,98	8,61%	1,18%	US$ 36,24 B	1,28%
PHG	127,59	2,23	1,75%	3,13%	US$ 26,81 B	1,07%
DXCM	56,42	12,53	22,21%	0,00%	US$ 32,25 B	13,29%
RMD	30,62	7,19	23,47%	0,72%	US$ 42,88 B	27,22%

comparison of BSX with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history BSX dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Boston Scientific

Boston Scientific Corp.

Average user rating I10

4.0 (28 people)

Estados Unidos

46 years

Foundation: 1979

1992

Year of debut on the stock exchange - 33 years

36.000

Employees

Additional Information

The Company Boston Scientific Corp. (Estados Unidos), is listed on NYSE with a market value of $ 157,13 Billions, having a net worth of $ 22,65 Billions.

With a total of 36.000 employees, the company is listed in the sector of Saúde and categorized in industry of Materiais e Equipamentos Médicos.

In the last 12 months the Company had a revenue of $ 18,49 Billions, which generated a profit in the amount of $ 2,51 Billions.

As for its main indicators, the Company has a P/E ratio of 62,73, a P/B ratio of 6,94 and in the last 12 months the Company did not pay dividends.

The Company is traded in Brazil through the BDR B1SX34, or can be purchased on abroad through the ticker BSX.

Market value

US$ 157,13 Billions

Net worth

US$ 22,65 Billions

US$ 22.653.000.000,00

Assets

US$ 41,56 Billions

US$ 41.559.000.000,00

Total Number of Shares

1,48 Billion

1.480.000.000

Average Daily Trading Volume

US$ 7,31 Milhões

US$ 7.310.096,00

Sector

Saúde

Industry

Materiais e Equipamentos Médicos

BSX

BSX revenue and profits

BSX results

DRAG THE FRAME TO SEE MORE DATA

BSX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12 M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12 M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12 M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12 M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12 M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12 M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12 M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

Common Questions

What is the price of Boston Scientific (BSX) today?

The price of Boston Scientific (BSX) today is R$ 578,76, with a variation of 33.87% compared to the last year. The price of Boston Scientific (BSX) started the year trading around R$ 485,90 and today it is at R$ 578,76. Follow the real-time price chart, the historical price of Boston Scientific (BSX), and stock data from Ibovespa and international markets.

When does Boston Scientific (BSX) pay dividends?

Boston Scientific (BSX) did not distribute dividends in the last year.

Boston Scientific (BSX) is it worth it?

Currently, Boston Scientific (BSX) is priced at R$ 578,76, with a P/E of 62,73%, representing a deviation of 68,09% from its historical average P/E. In the last year, the stock showed a variation of 33.87% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 33,87%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Boston Scientific (BSX)?

Investing in shares of Boston Scientific (BSX) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Boston Scientific (BSX) yield today?

The yield of Boston Scientific (BSX) was 0,24% in the last month, 33,87% in the last year and 159,30% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Boston Scientific (BSX) today, the total investment would be based on the current price of R$ 578,76.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 77.478,82
In 5 years: R$ 150.072,88
In 10 years: 367.826,15

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

BSX

Boston Scientific Corp.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of BSX

check out the fundamentals of Boston Scientific shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Boston Scientific

Boston Scientific Corp.

Estados Unidos

46 years

1992

36.000

Additional Information

PROFIT X PRICE BSX

BSX results

BSX cash flow

evolution of assets - BSX

BSX balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80